| UniProt ID | EFTS_HUMAN | |
|---|---|---|
| UniProt AC | P43897 | |
| Protein Name | Elongation factor Ts, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03135} | |
| Gene Name | TSFM {ECO:0000255|HAMAP-Rule:MF_03135} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 325 | |
| Subcellular Localization | Mitochondrion. | |
| Protein Description | Associates with the EF-Tu.GDP complex and induces the exchange of GDP to GTP. It remains bound to the aminoacyl-tRNA.EF-Tu.GTP complex up to the GTP hydrolysis stage on the ribosome.. | |
| Protein Sequence | MSLLRSLRVFLVARTGSYPAGSLLRQSPQPRHTFYAGPRLSASASSKELLMKLRRKTGYSFVNCKKALETCGGDLKQAEIWLHKEAQKEGWSKAAKLQGRKTKEGLIGLLQEGNTTVLVEVNCETDFVSRNLKFQLLVQQVALGTMMHCQTLKDQPSAYSKGFLNSSELSGLPAGPDREGSLKDQLALAIGKLGENMILKRAAWVKVPSGFYVGSYVHGAMQSPSLHKLVLGKYGALVICETSEQKTNLEDVGRRLGQHVVGMAPLSVGSLDDEPGGEAETKMLSQPYLLDPSITLGQYVQPQGVSVVDFVRFECGEGEEAAETE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 22 | Phosphorylation | TGSYPAGSLLRQSPQ CCCCCCCHHHCCCCC | 26.74 | - | |
| 33 | Phosphorylation | QSPQPRHTFYAGPRL CCCCCCCEEECCCCC | 21.44 | 24719451 | |
| 35 | Phosphorylation | PQPRHTFYAGPRLSA CCCCCEEECCCCCCC | 16.29 | 24719451 | |
| 41 | Phosphorylation | FYAGPRLSASASSKE EECCCCCCCCCCCHH | 22.81 | 26552605 | |
| 43 | Phosphorylation | AGPRLSASASSKELL CCCCCCCCCCCHHHH | 25.88 | 26552605 | |
| 45 | Phosphorylation | PRLSASASSKELLMK CCCCCCCCCHHHHHH | 39.17 | 26552605 | |
| 46 | Phosphorylation | RLSASASSKELLMKL CCCCCCCCHHHHHHH | 29.84 | 26552605 | |
| 52 | Malonylation | SSKELLMKLRRKTGY CCHHHHHHHHHHHCC | 38.52 | 26320211 | |
| 52 | Acetylation | SSKELLMKLRRKTGY CCHHHHHHHHHHHCC | 38.52 | 27452117 | |
| 56 | Malonylation | LLMKLRRKTGYSFVN HHHHHHHHHCCCEEC | 39.61 | 26320211 | |
| 56 | Succinylation | LLMKLRRKTGYSFVN HHHHHHHHHCCCEEC | 39.61 | 27452117 | |
| 59 | Phosphorylation | KLRRKTGYSFVNCKK HHHHHHCCCEECHHH | 12.27 | - | |
| 65 | Succinylation | GYSFVNCKKALETCG CCCEECHHHHHHHCC | 35.56 | 23954790 | |
| 65 | Acetylation | GYSFVNCKKALETCG CCCEECHHHHHHHCC | 35.56 | 25953088 | |
| 66 | Ubiquitination | YSFVNCKKALETCGG CCEECHHHHHHHCCC | 61.48 | - | |
| 71 | S-nitrosylation | CKKALETCGGDLKQA HHHHHHHCCCCHHHH | 4.13 | 19483679 | |
| 71 | S-nitrosocysteine | CKKALETCGGDLKQA HHHHHHHCCCCHHHH | 4.13 | - | |
| 76 | Succinylation | ETCGGDLKQAEIWLH HHCCCCHHHHHHHHH | 52.80 | - | |
| 76 | Acetylation | ETCGGDLKQAEIWLH HHCCCCHHHHHHHHH | 52.80 | 25953088 | |
| 76 | Succinylation | ETCGGDLKQAEIWLH HHCCCCHHHHHHHHH | 52.80 | - | |
| 76 | Malonylation | ETCGGDLKQAEIWLH HHCCCCHHHHHHHHH | 52.80 | 26320211 | |
| 84 | Ubiquitination | QAEIWLHKEAQKEGW HHHHHHHHHHHHHCH | 53.20 | - | |
| 84 | Acetylation | QAEIWLHKEAQKEGW HHHHHHHHHHHHHCH | 53.20 | 26051181 | |
| 133 | Succinylation | DFVSRNLKFQLLVQQ CCCCCHHHHHHHHHH | 34.31 | - | |
| 133 | Succinylation | DFVSRNLKFQLLVQQ CCCCCHHHHHHHHHH | 34.31 | - | |
| 160 | Phosphorylation | KDQPSAYSKGFLNSS CCCCCHHHCCCCCHH | 26.47 | 23401153 | |
| 161 (in isoform 1) | Ubiquitination | - | 40.79 | 21890473 | |
| 161 | Ubiquitination | DQPSAYSKGFLNSSE CCCCHHHCCCCCHHH | 40.79 | 21906983 | |
| 183 | Ubiquitination | PDREGSLKDQLALAI CCCCCCHHHHHHHHH | 45.16 | - | |
| 192 | Succinylation | QLALAIGKLGENMIL HHHHHHHHHCCCHHE | 47.40 | 2189047 | |
| 192 | Ubiquitination | QLALAIGKLGENMIL HHHHHHHHHCCCHHE | 47.40 | 21890473 | |
| 192 (in isoform 1) | Ubiquitination | - | 47.40 | 21890473 | |
| 192 | Acetylation | QLALAIGKLGENMIL HHHHHHHHHCCCHHE | 47.40 | 23236377 | |
| 192 | Succinylation | QLALAIGKLGENMIL HHHHHHHHHCCCHHE | 47.40 | - | |
| 192 | Ubiquitination | QLALAIGKLGENMIL HHHHHHHHHCCCHHE | 47.40 | - | |
| 200 | Ubiquitination | LGENMILKRAAWVKV HCCCHHEEEEEEEEC | 29.12 | - | |
| 212 | Phosphorylation | VKVPSGFYVGSYVHG EECCCCCCCCHHHCC | 13.87 | 17053785 | |
| 213 (in isoform 2) | Ubiquitination | - | 3.71 | 21890473 | |
| 216 | Phosphorylation | SGFYVGSYVHGAMQS CCCCCCHHHCCCCCC | 7.19 | 17053785 | |
| 223 | Phosphorylation | YVHGAMQSPSLHKLV HHCCCCCCCCHHHHH | 11.90 | - | |
| 240 | S-nitrosylation | KYGALVICETSEQKT CCCEEEEECCCCCCC | 3.48 | 19483679 | |
| 240 | S-nitrosocysteine | KYGALVICETSEQKT CCCEEEEECCCCCCC | 3.48 | - | |
| 246 | Ubiquitination | ICETSEQKTNLEDVG EECCCCCCCCHHHHH | 35.02 | - | |
| 263 | Sulfoxidation | LGQHVVGMAPLSVGS HHHCCEEECCCCCCC | 2.04 | 21406390 | |
| 267 | Phosphorylation | VVGMAPLSVGSLDDE CEEECCCCCCCCCCC | 24.31 | 28450419 | |
| 270 | Phosphorylation | MAPLSVGSLDDEPGG ECCCCCCCCCCCCCC | 26.86 | 25159151 | |
| 281 | Phosphorylation | EPGGEAETKMLSQPY CCCCCCCHHCCCCCE | 28.89 | 28450419 | |
| 291 (in isoform 2) | Phosphorylation | - | 32.10 | 27251275 | |
| 324 | Phosphorylation | EGEEAAETE------ CCHHHHCCC------ | 42.12 | 25159151 | |
| 345 (in isoform 2) | Phosphorylation | - | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EFTS_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EFTS_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EFTS_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RRFM_HUMAN | MRRF | physical | 22939629 | |
| AT7L2_HUMAN | ATXN7L2 | physical | 28514442 | |
| IF2M_HUMAN | MTIF2 | physical | 28514442 | |
| CYTT_HUMAN | CST2 | physical | 28514442 | |
| CYTS_HUMAN | CST4 | physical | 28514442 | |
| ZG16B_HUMAN | ZG16B | physical | 28514442 | |
| TRUA_HUMAN | PUS1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 610505 | Combined oxidative phosphorylation deficiency 3 (COXPD3) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-212 AND TYR-216, ANDMASS SPECTROMETRY. | |